Literature DB >> 18074737

Clinical, biochemical and histological correlations in a group of non-drinker subjects with non-alcoholic fatty liver disease.

B Canbakan1, H Senturk, V Tahan, I Hatemi, H Balci, T Toptas, A Sonsuz, M Velet, S Aydin, A Dirican, S Ozgulle, G Ozbay.   

Abstract

The correlation between biochemistry, imaging-studies and histology is a matter of controversy in non-alcoholic fatty liver disease (NAFLD) and the major pathophysiology of non-alcoholic steatohepatitis (NASH) is still unknown. We aimed to perform a comparative analysis between clinical, biochemical and histological variables of NAFLD. One-hundred and five NAFLD patients (F/M: 51/54), were studied, all with no-alcohol intake. The groups were followed-up for six months. Necroinflammation and fibrosis were more severe in patients with diabetes (p = 0.002, and p = 0.0001, respectively). In comparing NAFL to NASH, plasma nitric-oxide and malondialdehyde levels were significantly higher (p = 0.05, for-both), and vitamin-E and-C levels were significantly lower in NASH (p = 0.002, and 0.001, respectively). The serum ferritin levels were higher in NASH patients (p = 0.016). While the ultrasonographic grade was significantly higher, the liver-spleen density gradient was significantly lower in NASH group (p = 0.017, and 0.005, respectively). Within a six month period, serum ALT levels dropped into the normal range in 23/76 (30.3%) patients and serum ALT in the 6th month correlated significantly with the severity of steatosis, inflammation and fibrosis in initial biopsy (p = 0.023, 0.035, 0.011, respectively). In conclusion, the probability of severe liver disease is higher in patients with elevated-ALT in NAFLD. Serum ferritin levels have some prognostic significance in liver damage and fibrosis. Overt diabetes is predictive of advanced fibrosis and inflammation. However impaired glucose-tolerance is not. The advice on diet and exercise for six months after diagnosis may be a good strategy in NAFLD. The patients with normal-ALT without hepatomegaly, morbid-obesity and diabetes seem to have a good prognosis, however some of these patients may still require liver biopsy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18074737

Source DB:  PubMed          Journal:  Acta Gastroenterol Belg        ISSN: 1784-3227            Impact factor:   1.316


  12 in total

1.  Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels?

Authors:  Lucia Carulli; Stefano Ballestri; Amedeo Lonardo; Francesca Lami; Enrico Violi; Luisa Losi; Lisa Bonilauri; Anna Maria Verrone; Maria Rosaria Odoardi; Federica Scaglioni; Marco Bertolotti; Paola Loria
Journal:  Intern Emerg Med       Date:  2011-05-11       Impact factor: 3.397

2.  Risk factors and mechanisms of non-alcoholic steatohepatitis.

Authors:  Chantal A Rivera
Journal:  Pathophysiology       Date:  2008-07-29

3.  The formation of intracellular glyceraldehyde-derived advanced glycation end-products and cytotoxicity.

Authors:  Jun-ichi Takino; Yuka Kobayashi; Masayoshi Takeuchi
Journal:  J Gastroenterol       Date:  2010-01-19       Impact factor: 7.527

Review 4.  From fatty liver to fibrosis: a tale of "second hit".

Authors:  Metin Basaranoglu; Gökcen Basaranoglu; Hakan Sentürk
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

5.  Noninvasive quantitation of human liver steatosis using magnetic resonance and bioassay methods.

Authors:  Gaspard d'Assignies; Martin Ruel; Abdesslem Khiat; Luigi Lepanto; Miguel Chagnon; Claude Kauffmann; An Tang; Louis Gaboury; Yvan Boulanger
Journal:  Eur Radiol       Date:  2009-03-11       Impact factor: 5.315

6.  Association between posttraumatic stress disorder following myocardial infarction and liver enzyme levels: a prospective study.

Authors:  Roland von Känel; Chiara C Abbas; Stefan Begré; Marie-Louise Gander; Hugo Saner; Jean-Paul Schmid
Journal:  Dig Dis Sci       Date:  2009-12-24       Impact factor: 3.199

Review 7.  Melatonin: a potential intervention for hepatic steatosis.

Authors:  Hang Sun; Fang-fang Huang; Shen Qu
Journal:  Lipids Health Dis       Date:  2015-07-22       Impact factor: 3.876

Review 8.  Does vitamin C deficiency promote fatty liver disease development?

Authors:  David Højland Ipsen; Pernille Tveden-Nyborg; Jens Lykkesfeldt
Journal:  Nutrients       Date:  2014-12-01       Impact factor: 5.717

9.  Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis.

Authors:  Shui-Xian Du; Lin-Lin Lu; Ning Geng; David W Victor; Li-Zhen Chen; Cong Wang; Hai-Yan Yue; Yong-Ning Xin; Shi-Ying Xuan; Wen-Wen Jin
Journal:  Lipids Health Dis       Date:  2017-12-02       Impact factor: 3.876

10.  Association between Dietary Vitamin C Intake and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study among Middle-Aged and Older Adults.

Authors:  Jie Wei; Guang-Hua Lei; Lei Fu; Chao Zeng; Tuo Yang; Shi-Fang Peng
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.